ArticleJournal of nephrology2016

Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis.

Jukka M Rintala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.